Knockdown of TRIM28 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration.

[1]  P. K. Sharma.  Atherosclerosis. , 2020, The Journal of the Association of Physicians of India.

[2]  K. Pietras,et al.  PDGF family function and prognostic value in tumor biology. , 2018, Biochemical and biophysical research communications.

[3]  Xunzhong Dong,et al.  CTRP6 inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[4]  N. Katakami.  Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus , 2018, Journal of atherosclerosis and thrombosis.

[5]  Hai-Jian Sun,et al.  Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade , 2017, Redox biology.

[6]  G. P. V. van Hout,et al.  The Inflammasomes in Cardiovascular Disease. , 2018, Experientia supplementum.

[7]  Yan Zhu,et al.  A newly synthesized Ligustrazine stilbene derivative inhibits PDGF‐BB induced vascular smooth muscle cell phenotypic switch and proliferation via delaying cell cycle progression , 2017, European journal of pharmacology.

[8]  Przemysław Biecek,et al.  TRIM28 epigenetic corepressor is indispensable for stable induced pluripotent stem cell formation. , 2017, Stem cell research.

[9]  M. Fu,et al.  Expression profiling of TRIM protein family in THP1-derived macrophages following TLR stimulation , 2017, Scientific Reports.

[10]  Jinping Li,et al.  Tripartite motif–containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR‐1 and −2 and VEGFR2 in endothelial cells , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  Jingliang Cheng,et al.  Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein , 2016, Scientific Reports.

[12]  J. Hong,et al.  Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches , 2016, Cells.

[13]  P. Libby,et al.  Atherosclerosis: Successes, Surprises, and Future Challenges. , 2016, Circulation research.

[14]  J. Stark,et al.  RNF4 regulates DNA double-strand break repair in a cell cycle-dependent manner , 2016, Cell cycle.

[15]  Y. Pi,et al.  An overview of potential molecular mechanisms involved in VSMC phenotypic modulation , 2015, Histochemistry and Cell Biology.

[16]  A. Orekhov,et al.  Vascular smooth muscle cell in atherosclerosis , 2015, Acta physiologica.

[17]  Bao-qin Liu,et al.  Atorvastatin Calcium Inhibits Phenotypic Modulation of PDGF-BB-Induced VSMCs via Down-Regulation the Akt Signaling Pathway , 2015, PloS one.

[18]  Xi-Long Zheng,et al.  Nuclear Factor-κB Activation as a Pathological Mechanism of Lipid Metabolism and Atherosclerosis. , 2015, Advances in clinical chemistry.

[19]  Y. Mao,et al.  TRIM28 as an independent prognostic marker plays critical roles in glioma progression , 2015, Journal of Neuro-Oncology.

[20]  M. Hayashi,et al.  Smooth Muscle–Selective Inhibition of Nuclear Factor‐κB Attenuates Smooth Muscle Phenotypic Switching and Neointima Formation Following Vascular Injury , 2013, Journal of the American Heart Association.

[21]  Mark J. Davies,et al.  The epigenetic phenotypic switch of vascular smooth muscle cells involved in atherosclerosis , 2013, The Lancet.

[22]  Dawei Xu,et al.  TRIM28, a new molecular marker predicting metastasis and survival in early-stage non-small cell lung cancer. , 2013, Cancer epidemiology.

[23]  A. Baker,et al.  How do microRNAs affect vascular smooth muscle cell biology? , 2012, Current opinion in lipidology.

[24]  D. Solter,et al.  Trim28 Is Required for Epigenetic Stability During Mouse Oocyte to Embryo Transition , 2012, Science.

[25]  Han Mei.  Effect of PDGF-BB on expression of phenotypic markers in vascular smooth muscle cells , 2010 .

[26]  T. Gilmore.  Introduction to NF-κB: players, pathways, perspectives , 2006, Oncogene.

[27]  E. Hijová.  Matrix metalloproteinases: their biological functions and clinical implications. , 2005, Bratislavske lekarske listy.

[28]  A. Zernecke,et al.  Chemokines: Key Regulators of Mononuclear Cell Recruitment in Atherosclerotic Vascular Disease , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .